Alpha Omega: Beneficial effect of low doses of n-3 fatty acids only found in sub-groups of post-MI patients

Results from the Alpha Omega Trial, a multicentre, placebo-controlled trial in men and women following myocardial infarction (MI), suggest that low doses of n-3 fatty acids given in the form of enriched margarines do not reduce the overall rate of major cardiovascular events.

Read the whole article on Physorg

More from Physorg